Abstract Elderly patients are commonly characterized by the presence of several chronic aging-related diseases at once, or old-age Bmultimorbidity,^with critical implications for diagnosis and therapy. However, at the present there is no agreed or formal method to diagnose or even define Bmultimorbidity.T here is also no formal quantitative method to evaluate the effects of individual or combined diagnostic parameters and therapeutic interventions on multimorbidity. The present work outlines a methodology to provide such a measurement and definition, using information theoretical measure of normalized mutual information. A cohort of geriatric patients, suffering from several age-related diseases (multimorbidity), including ischemic heart disease, COPD, and dementia, were evaluated by a variety of diagnostic parameters, including static as well as dynamic biochemical, functional-behavioral, immun o l o g i c a l , a n d h e m a t o l o g i c a l p a r a m e t e r s . Multimorbidity was formally coded and measured as a composite of several chronic age-related diseases. The normalized mutual information allowed establishing the exact informative value of particular parameters and their combinations about the multimorbidity value. With the currently intensifying attempts to reduce aging-related multimorbidity by therapeutic interventions into its underlying aging processes, the proposed method may outline a valuable direction toward the formal indication and evidence-based evaluation of effectiveness of such interventions.
Introduction
With the growing aging population, and the accompanying growing incidence of aging-related diseases, there is an increasing need to improve the diagnostic and therapeutic capabilities for those diseases (Jin et al. 2015) . However, the diagnosis and treatment of elderly patients is often greatly complicated by the presence in these patients of several chronic aging-related diseases at once, or age-related Bmultimorbidity.^Currently, there is no agreed or formal method to diagnose or even define Bmultimorbidity^ (Salive 2013) . There are also no agreed and formal methods to evaluate the diagnostic ability of particular diagnostic parameters or their combinations to diagnose multimorbidity. There is an urgent need to develop such quantifiable definitions of multimorbidity and of the effects of diagnostic and therapeutic factors for the elderly population. This need is emphasized by the growing realization of the determinative impact of degenerative aging processes on the emergence of age-related multimorbidity (Rae et al. 2010; Fontana et al. 2014; Goldman et al. 2013 ). There are now intensifying attempts to reduce old-age multimorbidity by therapeutically intervening into its underlying aging processes (Hall 2015; Newman et al. 2016) . However, in order to estimate the success or failure of such interventions, there is a critical need to be able to reliably and quantitatively evaluate the multimorbidity and dynamic changes in it. The present work outlines a methodology to provide such a capability, using information-theoretical measure of normalized mutual information.
It is yet far from solving the problem of precise quantitative diagnostic evaluation of old-age multimorbidity. However, the information-theoretical methodology may offer some directions for the solution. This is due to the fact that information-theoretical measures (such as normalized mutual information, as employed in this study) allow the researchers to evaluate the exact quantitative correlation between any combined group of parameters (such as a combined group of diagnostic markers) with any other combined group of parameters (such as multimorbidity composed from several diseases). Moreover, the information-theoretical methodology uniquely permits the evaluation of cumulative, synergistic, or holistic relations between such combinations (Blokh and Stambler 2016) . Such synergistic effects of combinations of parameters are impossible to establish by other methodologies, such as simple arithmetic Bscoring^that is sometimes used for the evaluation of multimorbidity.
This capability is exemplified here using a data base on geriatric patients, including some routinely available biochemical, cellular and physiological parameters, and several prevalent age-related diseases, namely ischemic heart disease (IHD), dementia, and COPD. Multimorbidity is here formally coded and measured as a composite of several chronic age-related diseases, in fact producing a new single disease entity-Bthe multimorbidity^-out of several diseases (see the section Mathematical analysis below).
Methods

Mathematical analysis
In this work, in order to formally measure old-age multimorbidity, we use the information-theoretical measure of correlation of individual or combined diagnostic parameters with individual diseases or multimorbidity, namely the measure of normalized mutual information (NMI), also known as the uncertainty coefficient. The normalized mutual information value tells the exact amount of information that each diagnostic parameter or combination of parameters contain about the multimorbidity value.
Briefly, the normalized mutual information is determined as follows. Let X be a discrete random value with a distribution function.
X-can be a biomarker, n-the number of categories of the marker, p i -the frequency of the category x i . The entropy of random value X is:
Let X,Y be the discrete random values (parameters). The algorithms for the determination of normalized mutual information between parameters or their combinations have been presented earlier (Blokh and Stambler 2015a; Blokh and Stambler 2017) . Very briefly, for the parameters X,Y, we calculate the value of normalized mutual information c, by the following formula:
where H(X), H(Y), and H(X,Y) are the entropies of random variables X, Y, and X×Y, respectively. The values of the uncertainty coefficient (normalized mutual information) closer to zero indicate a smaller degree of correlation, while the coefficient values closer to 1 indicate a larger degree of correlation. In order to estimate the correlation between a combined marker and a single disease, we need to estimate the combined correlation of all the markers comprising the combined marker with the disease. For a combined
marker comprised of two markers, this is done in the following way: Let the combined marker Z be comprised of two discrete markers z 1 and z 2 , while the marker z 1 assumes two values: 0 and 1, and the marker z 2 assumes three values: 0, 1, and 2. Then, the correlation of the combined marker Z with the disease is estimated by the correlation of a Bsingle marker^assuming 6 values in accordance to the values of the single markers z 1 and z 2 :
We can proceed in the same way for combined markers comprised by more than two markers. In this study, instead of a single disease (e.g., IHD), we introduce a new disease entity-the Bmultimorbidity.T he diseased state of Bmultimorbidity^is a composite of the diseases the patient has. For the present study, the composite Bmultimorbidity^variable is composed of three diseases: IHD, chronic obstructive pulmonary disease (COPD), and dementia. But the composite Bmultimorbidity^can be comprised from any number of diseases and morbid or disabled states as relevant for the particular study or clinical setting. We code the Bmultimorbidity^as a single discrete disease entity assuming several possible states, according to the presence or absence of particular diseases, as follows:
Here, 0 indicates absence of a disease, and 1 indicates presence of a disease. The final column indicates the state codes for the multimorbidity variable. For example, if both IHD and dementia are present, but not COPD, then the multimorbidity code is 5. In other words, we consider a single composite disease-the Bmultimorbidity^-that can assume 8 discrete states.
Case materials
This work is based on the analysis of 197 patients (male and female, aged 63-97) treated for hip fracture at the Geriatric Medical Center BShmuel Harofe^in Beer Yaakov, Israel. Access to the patients' data was obtained according to the principles of the Declaration of Helsinki. Out of all the analytical parameters on the patients, several parameters were chosen to illustrate the methodology presented in this article. The parameters were selected to represent different kinds of analysis: microelements (potassium-K and sodium-Na levels), cellular/ immunological (number of lymphocytes-Lym and white blood cells-WBC), hematological (number of thrombocytes-Thr, hemoglobin-Hb), physiological (heart rate-pulse), metabolic (glucose), and functional/behavioral evaluations, namely different types of functional independence measurements-FIM, such as total FIM (Tfim), cognitive FIM (Cfim), and motor FIM (Mfim) (Linacre et al. 1994; Dodds et al. 1993) .
Data were evaluated at admission (ad) and discharge from the hospital (dis). Moreover, based on the admission and discharge data, the dynamic change and stability of the parameters were estimated for several parameters as percent positive or negative change above and below a certain threshold: Lym + 10%, Lym − 10%, Thr + 10%, Thr − 10%, Pulse + 5%, Pulse − 5%, Na + 1%, Na − 1%, Gluc + 10%, Gluc − 10%, Hb > + 15%, Hb > − 15%, WBC + 1%, WBC − 1%. Increases or decreases beyond the threshold boundaries may indicate excessive instability of the parameters, potentially indicative of impaired homeostatic/regulatory capacity of the organism. For example, the parameter Lym + 10% was assumed to equal 1, if during the hospital stay, the amount of lymphocytes increased by 10% and more, and 0 otherwise. The parameter Lym − 10% was assumed to be 1, if during the hospital stay, the number of lymphocytes decreased by 10% and more, and 0 otherwise. The thresholds were selected according to the algorithm for boundaries determination by maximizing normalized mutual information (Blokh and Stambler 2015b) for the entire patients' cohort. The patients' age and gender were also included as necessary discriminative parameters. Altogether, 42 parameters are considered. The parameters and the parameters' combinations were correlated with the multimorbidity variable, composed of three degenerative diseases of different organ systems: IHD, COPD, and dementia. The multimorbidity variable was coded as a single disease that can assume eight states, according to the presence or absence of each of the particular diseases. 
Results and discussion
Using the above methodology, first we correlated individual diagnostic parameters with the multimorbidity variable (assuming eight states according to the presence or absence of particular diseases-IHD, COPD, and dementia. The results are shown in Table 1 . As it can be seen in Table 1 , the most informative parameters for the evaluation of multimorbidity were the functional evaluations-cognitive functional independence measurement (Cfim) at admission and at discharge, total functional independence measurements (Tfim) at admission and discharge, and motor functional independence measurements (Mfim) at discharge. These functional parameters have the highest informative values (NMI), ranging from 0.0954 for Cfimdis down to 0.05406 for Tfimad. Generally, the biomarkers-including the cellular, immunological, biochemical, and physiological parameters-were found to be less informative than the behavioral-functional measurements. Among the biomarkers, following the above functional measurements, the highest NMI value was found for glucose at admission and discharge -0.05372 and 0.0441, respectively. This may emphasize the important role of glycation as a fundamental mechanism of aging for the emergence of multiple aging-related diseases (Semba et al. 2010) . Incidentally, the recently quite famous TAME studyBTargeting Aging with Metformin^that aims to reduce age-related multimorbidity by intervening into its underlying aging process, utilizes the well-known antidiabetic biguanide drug-metformin, which is a Bglucophage^with a primary function of reducing glucose and the corresponding glycation (Hall 2015; Newman et al. 2016 ). The present findings further emphasize the potential role of glucose levels as an indicator or predictor of multimorbidity.
Still, the functional parameters were more informative. This may be partly explained by the specific nature of the functional tests for the diseases under consideration (e.g., the specific implications of cognitive functional independence measurements for the presence of dementia). Being relatively inexpensive and easily applicable by the geriatric physicians, the functional tests can thus provide a good and convenient indication of the multimorbidity status. The use of the biomarkers was more uncertain as indicators of the multimorbidity. Among the biomarkers, somewhat informative was the negative change of thrombocytes (potentially indicative of the state of the blood clotting system), with the NMI = 0.02228. Gender also provided additional informative value (NMI = 0.02215). When combining two diagnostic markers, the informative value regarding multimorbidity increased. The NMI correlations between combined double markers and the multimorbidity variable are shown in Table 2 . Interestingly, the most informative combinations correlating with multimorbidity combined both functional parameters and a specific biomarker (glucose). Thus, the most informative combined parameter was Cfim at discharge together with glucose at admission (NMI = 0.15934) and Cfim at discharge with glucose at discharge (NMI = 0.14889). Notice the cumulative (synergistic) effect that is produced by such a combination. Thus, for Cfimdis NMI = 0.0954 and for glucose ad, NMI = 0.05372, giving the simple arithmetic sum of NMI = 0.14912, which is less than the cumulative value of the combination of these two parameters: NMI = 0.15934. This may indicate the importance of combining functional measurements with biomarkers measurements.
The combination of different types of functional measurements also increases the informative value (NMI = 0.13497 for Cfmindis together with Mfimdis). The cognitive functional performance appears in the most informative pairs at discharge, after the experience of hip fracture and often painful treatments, possibly indicating the degree of cognitive resilience. Generally, the geriatric cohort under consideration included multiple treatment factors that may complicate the interpretation. Interestingly, age appeared to be of little informative value, either alone or in combinations. This may be characteristic of the particular geriatric sample under consideration, with subjects aged 63-97. Nonetheless, despite those complications, the present methodology permitted to establish good informative values for the correlation of diagnostic parameters and the multimorbidity variable.
Conclusion
The present study offers a methodology to formally describe the multimorbidity variable composed from several age-related diseases, and to find the most informative diagnostic parameters and parameters' combinations for the precise quantitative evaluation of the multimorbidity variable. So far such a formal agreed methodology had been absent, but it is strongly needed to evaluate elderly geriatric patients, who are as a rule characterized by multimorbidity. It may be particularly helpful to evaluate the effects of aging-ameliorating treatments on aging-derived multimorbidity. The study demonstrated the principal applicability of this methodology in a situation most common for actual clinical geriatric settings. Further analysis of additional diverse clinical data, including data on therapeutic interventions, will improve the clinical utility of such a methodology.
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